Glucose sensitive insulin - Novo Nordisk
Alternative Names: Glucose sensitive insulin-Novo NordiskLatest Information Update: 02 Mar 2022
Price :
$50 *
At a glance
- Originator Novo Nordisk
- Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 16 Feb 2022 Phase-I clinical trials in Type 1 diabetes mellitus in Denmark (unspecified route) (Novo Nordisk pipeline, February 2022)
- 16 Feb 2022 Phase-I clinical trials in Type 2 diabetes mellitus in Denmark (unspecified route) (Novo Nordisk pipeline, February 2022)